Cargando…
The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
BACKGROUND: The R47H variant of the Triggering Receptor Expressed on Myeloid cells 2 (TREM2) significantly increases the risk for late onset Alzheimer’s disease. Mouse models accurately reproducing phenotypes observed in Alzheimer’ disease patients carrying the R47H coding variant are required to un...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126019/ https://www.ncbi.nlm.nih.gov/pubmed/30185230 http://dx.doi.org/10.1186/s13024-018-0280-6 |
_version_ | 1783353256743796736 |
---|---|
author | Xiang, Xianyuan Piers, Thomas M. Wefers, Benedikt Zhu, Kaichuan Mallach, Anna Brunner, Bettina Kleinberger, Gernot Song, Wilbur Colonna, Marco Herms, Jochen Wurst, Wolfgang Pocock, Jennifer M. Haass, Christian |
author_facet | Xiang, Xianyuan Piers, Thomas M. Wefers, Benedikt Zhu, Kaichuan Mallach, Anna Brunner, Bettina Kleinberger, Gernot Song, Wilbur Colonna, Marco Herms, Jochen Wurst, Wolfgang Pocock, Jennifer M. Haass, Christian |
author_sort | Xiang, Xianyuan |
collection | PubMed |
description | BACKGROUND: The R47H variant of the Triggering Receptor Expressed on Myeloid cells 2 (TREM2) significantly increases the risk for late onset Alzheimer’s disease. Mouse models accurately reproducing phenotypes observed in Alzheimer’ disease patients carrying the R47H coding variant are required to understand the TREM2 related dysfunctions responsible for the enhanced risk for late onset Alzheimer’s disease. METHODS: A CRISPR/Cas9-assisted gene targeting strategy was used to generate Trem2 R47H knock-in mice. Trem2 mRNA and protein levels as well as Trem2 splicing patterns were assessed in these mice, in iPSC-derived human microglia-like cells, and in human brains from Alzheimer’s patients carrying the TREM2 R47H risk factor. RESULTS: Two independent Trem2 R47H knock-in mouse models show reduced Trem2 mRNA and protein production. In both mouse models Trem2 haploinsufficiency was due to atypical splicing of mouse Trem2 R47H, which introduced a premature stop codon. Cellular splicing assays using minigene constructs demonstrate that the R47H variant induced abnormal splicing only occurs in mice but not in humans. TREM2 mRNA levels and splicing patterns were both normal in iPSC-derived human microglia-like cells and patient brains with the TREM2 R47H variant. CONCLUSIONS: The Trem2 R47H variant activates a cryptic splice site that generates miss-spliced transcripts leading to Trem2 haploinsufficiency only in mice but not in humans. Since Trem2 R47H related phenotypes are mouse specific and do not occur in humans, humanized TREM2 R47H knock-in mice should be generated to study the cellular consequences caused by the human TREM2 R47H coding variant. Currently described phenotypes of Trem2 R47H knock-in mice can therefore not be translated to humans. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13024-018-0280-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6126019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61260192018-09-10 The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans Xiang, Xianyuan Piers, Thomas M. Wefers, Benedikt Zhu, Kaichuan Mallach, Anna Brunner, Bettina Kleinberger, Gernot Song, Wilbur Colonna, Marco Herms, Jochen Wurst, Wolfgang Pocock, Jennifer M. Haass, Christian Mol Neurodegener Research Article BACKGROUND: The R47H variant of the Triggering Receptor Expressed on Myeloid cells 2 (TREM2) significantly increases the risk for late onset Alzheimer’s disease. Mouse models accurately reproducing phenotypes observed in Alzheimer’ disease patients carrying the R47H coding variant are required to understand the TREM2 related dysfunctions responsible for the enhanced risk for late onset Alzheimer’s disease. METHODS: A CRISPR/Cas9-assisted gene targeting strategy was used to generate Trem2 R47H knock-in mice. Trem2 mRNA and protein levels as well as Trem2 splicing patterns were assessed in these mice, in iPSC-derived human microglia-like cells, and in human brains from Alzheimer’s patients carrying the TREM2 R47H risk factor. RESULTS: Two independent Trem2 R47H knock-in mouse models show reduced Trem2 mRNA and protein production. In both mouse models Trem2 haploinsufficiency was due to atypical splicing of mouse Trem2 R47H, which introduced a premature stop codon. Cellular splicing assays using minigene constructs demonstrate that the R47H variant induced abnormal splicing only occurs in mice but not in humans. TREM2 mRNA levels and splicing patterns were both normal in iPSC-derived human microglia-like cells and patient brains with the TREM2 R47H variant. CONCLUSIONS: The Trem2 R47H variant activates a cryptic splice site that generates miss-spliced transcripts leading to Trem2 haploinsufficiency only in mice but not in humans. Since Trem2 R47H related phenotypes are mouse specific and do not occur in humans, humanized TREM2 R47H knock-in mice should be generated to study the cellular consequences caused by the human TREM2 R47H coding variant. Currently described phenotypes of Trem2 R47H knock-in mice can therefore not be translated to humans. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13024-018-0280-6) contains supplementary material, which is available to authorized users. BioMed Central 2018-09-06 /pmc/articles/PMC6126019/ /pubmed/30185230 http://dx.doi.org/10.1186/s13024-018-0280-6 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Xiang, Xianyuan Piers, Thomas M. Wefers, Benedikt Zhu, Kaichuan Mallach, Anna Brunner, Bettina Kleinberger, Gernot Song, Wilbur Colonna, Marco Herms, Jochen Wurst, Wolfgang Pocock, Jennifer M. Haass, Christian The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans |
title | The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans |
title_full | The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans |
title_fullStr | The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans |
title_full_unstemmed | The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans |
title_short | The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans |
title_sort | trem2 r47h alzheimer’s risk variant impairs splicing and reduces trem2 mrna and protein in mice but not in humans |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126019/ https://www.ncbi.nlm.nih.gov/pubmed/30185230 http://dx.doi.org/10.1186/s13024-018-0280-6 |
work_keys_str_mv | AT xiangxianyuan thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT piersthomasm thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT wefersbenedikt thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT zhukaichuan thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT mallachanna thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT brunnerbettina thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT kleinbergergernot thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT songwilbur thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT colonnamarco thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT hermsjochen thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT wurstwolfgang thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT pocockjenniferm thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT haasschristian thetrem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT xiangxianyuan trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT piersthomasm trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT wefersbenedikt trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT zhukaichuan trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT mallachanna trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT brunnerbettina trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT kleinbergergernot trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT songwilbur trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT colonnamarco trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT hermsjochen trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT wurstwolfgang trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT pocockjenniferm trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans AT haasschristian trem2r47halzheimersriskvariantimpairssplicingandreducestrem2mrnaandproteininmicebutnotinhumans |